Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 80 results found. Search for [ Coronavirus GSK ]

Results 1 to 21 of 80
BusinessToday.In
May 28, 2021
\"Our next step is that we're going to offer vaccination to our school students, the teenagers, following which it'll be open season for everyone in Singapore,\" said Foreign Minister Vivian Balakrishnan


PB Jayakumar
May 27, 2021
Sotrovimab will be available for appropriate patients diagnosed with COVID-19 in the US in the coming weeks and discussions with global regulators regarding authorisations in additional countries continue to advance, said GSK


BusinessToday.In
May 21, 2021
Responding to a question on whether Bharat Biotech would be open to make the production of Covaxin open to other entities, Ella said this might not be the best way forward


PTI
May 18, 2021
During a daily virtual press briefing on Monday, the World Health Organisation Director-General said that the surge in COVID-19 cases around the world has compromised the global vaccine supply


PTI
May 18, 2021
China fully understands and is supportive of the developing world's demand for an IPR waiver for COVID-19 vaccines, Chinese Foreign Ministry spokesman Zhao Lijian told reporters in Beijing, without directly referring to India and South Africa's proposal


Reuters
May 17, 2021
Monday's announcement, however, comes as a relief for Sanofi and GSK after they were forced last December to restart their trial and delay the launch of the shot when the vaccine showed a low immune response in older adults as a result of a weak antigen formulation


PB Jayakumar
April 26, 2021
World Health Organisation (WHO)'s data on 'Landscape of candidate vaccines in clinical development' says a total of 91 vaccine candidates have reached the clinical development stage


Reuters
February 14, 2021
In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data


BusinessToday.In
February 8, 2021
Stock Market Live News Today: Sensex and Nifty continued hitting new all-time highs today. Both benchmarks hit fresh lifetime highs of 51,523 and 15,159 earlier today


Associated Press
January 8, 2021
Speaking during a news conference in Brussels on Friday, European Commission president Ursula von der Leyen said the agreement will double the amount of doses already ordered by the 27-nation bloc


Manoj Sharma
January 5, 2021
There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine


Ajita Shashidhar
New Delhi, December 24, 2020
Sanjiv Mehta delegated responsibility and relied on quick market feedback and cost control in order to thrive in the marketplace


PTI
December 24, 2020
India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm


BusinessToday.In
December 14, 2020
The humongous amounts of data that will be generated during the global vaccination process needs to be analysed almost real-time. That's where an integrated SCM suite embedded with emerging technology comes in


Associated Press
December 12, 2020
Two vaccine candidates stumbled on Friday in the race among researchers to combat Covid-19, even as the Pfizer jab nears approval in the US


BusinessToday.In
December 11, 2020
Apple Inc has historically had an office-centric culture and Cook has also expressed his desire for staff to ultimately return to the office in several public speaking forums


BusinessToday.In
December 11, 2020
GSK said phase 1/2 interim results showed an immune response comparable to patients who recovered from COVID-19 in adults aged 18 to 49 years but there was an insufficient response in older adults


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


BusinessToday.In
November 4, 2020
COVID-19 vaccine update: Based on the success of the trials and regulatory approvals, we can expect vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious, says SII CEO Adar Poonawalla


PTI
October 31, 2020
The UK is committed to ensuring that everyone at risk of SARS-CoV-2 infection, anywhere in the world, has access to a safe and effective vaccine, said Bingham


PAGES 1 OF 4  1234